A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BMI / bone marrow involvement

[Related PubMed/MEDLINE]
Total Number of Papers: 63
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BMI  (>> Co-occurring Abbreviation)
Long Form:   bone marrow involvement
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome. FL, HGBL
2020 Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement. BMB, CT, IPI, LDH, MTV, NHL, NPV, OS, PFS, PPV
2020 MRI versus 18F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance. BVC, MM
2020 Utility of bone marrow aspirate and biopsy in staging of patients with T-cell lymphoma in the PET-Era - tissue remains the issue. BMAB, OS, PET-CT, PFS, TCL
2019 18F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia. AL, BMB
2019 PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma. BMB, ENKTCL, OS, PET/CT, PFS
2019 The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers. BMB, ES, F-FDG, HL, NB, NHL, PET/CT
2018 Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphoma. BMB, FDG, PET/CT
2018 Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. BMB, DLBCL, HR, OS, PFS, TFs, VOI
10  2018 DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement. HUVEC
11  2018 Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy. BMB
12  2018 Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma. BMB, HL, PET/CT
13  2018 Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma. 3y-OS, 3y-PFS, DLBCL, ESR, R-CHOP
14  2018 The utility of bone marrow sampling in the diagnosis and staging of lymphoma in South Africa. BMB, HIV, HL, NHL
15  2018 [Incidence of Bone Marrow Involvement in Different Pathological Type Lymphoma Patients]. BMA, BMB, DLBCL, FL
16  2017 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement. BMB, PHL
17  2017 Efficacy of 18F-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computerized Tomography for Bone Marrow Infiltration Assessment in the Initial Staging of Lymphoma. 18F-FDG, BMB, HL, NHL, PET/CT
18  2017 PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma. BMB, DLBCL, OS, PET, PFS
19  2017 Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. ABVD, BM, HL
20  2017 Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography. BMB, cHL, FSL, PET/CT
21  2017 Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography. BMAB, DLBCL, PET-CT
22  2017 Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma. BMB
23  2017 Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma. BMB, DWI, WB-MRI
24  2017 [Change of NK Cell Number in Peripheral Blood of Patients with Mantle Cell Lymphoma and Its Clinical Significance]. ANKC, beta2-MG, Hb, LDH
25  2017 [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement]. DLBCL, LDH, OS, PFS
26  2017 [Clinical Significance of Detecting CD4+ T Cells in Peripheral Blood of Patients with Follicular lymphoma]. ACD4C, ACD8C, ALC, AMC, beta2-MG, Hb, LDH, OS, PFS, PLT
27  2016 (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. DLBCL, FL, HL, PET-CT
28  2016 Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. BMB, PTLD
29  2016 Exploring the role of bone marrow increased FDG uptake on PET/CT in patients with lymphoma-associated hemophagocytic lymphohistiocytosis: a reflection of bone marrow involvement or cytokine storm? BM, FDG, LAHLH, PET/CT
30  2016 High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era. DLBCL, IM, MTV, OS, PET/CT, PFS
31  2016 Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma. BMB, DLBCL, OS, PFS
32  2016 The prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma. BM, DLBCL
33  2015 Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma? aNHL, BMB, HL, PET/CT
34  2015 Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT. BMB, ENKL, OS, PFS
35  2015 High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy. BM, DLBCL, IHC
36  2014 Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT. HL, iBMB
37  2014 Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study. BMB, cHL, LDH, PET-CT
38  2014 [Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma]. aaIPI, ASCT, CR, DLBCL, OS, PFS, PR
39  2013 Fluoro-deoxy-glucose positron emission tomography/computed tomography in lymphoma: A pictorial essay. DLBCL, FDG, IHP, PET/CT
40  2013 In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. BMB, DLBCL
41  2013 Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. BMB, F-18 FDG, HL, PET/CT
42  2013 Significance of clinical factors as prognostic indicators for patients with peripheral T-cell non-Hodgkin lymphoma: A retrospective analysis of 252 cases. ECOG, IPI, LDH, OS, PTCL
43  2011 Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging? HL, NHL
44  2011 Incidence and risk factors of bone marrow involvement by non-Hodgkin lymphoma. Hb, LN, NHL
45  2010 The significance of bone marrow involvement in aggressive lymphomas: A retrospective comparison of clinical outcomes between peripheral T cell lymphoma and diffuse large B cell lymphoma in China. DLBCL, IPI, PTCL
46  2009 Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? BMU, CRP, HL, LDH, SU
47  2009 Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China. HSCT, LAHS, OS, PTCL, TCL
48  2009 [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma]. DLBCL
49  2008 Clinical and laboratorial prediction of bone marrow involvement in children and adolescents with Hodgkin Lymphoma. HL, RG
50  2008 [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases]. CR, HSCT, NHL, OS, PFS, RR
51  2007 Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement. DLT, NHL, RIT
52  2006 The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. DLCL, OS, PFS
53  2006 [Ultrastructural characteristics of malignant T cell in T cell lymphoma]. BMA, MTC
54  2005 Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. BM
55  2004 A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma. BMB, HL, LD, MC
56  2004 [Pathologic diagnosis and subtyping of lymphoma in bone marrow biopsies using histologic examination, immunohistochemistry and gene rearrangement studies]. CLL/SLL, DLBL, FCL, HCL, IgH, LPL, MCL, MZL
57  2003 [Analysis of alkaline phosphatase staining results in 238 cases of malignant lymphoma]. ALP, LCL
58  2002 The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. BMA, ESR, FBC, HL
59  2000 Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience. PS
60  2000 [Clinicopathological studies on bone marrow involvement of non-Hodgkin's lymphoma]. LCL, NHL
61  1996 Bone marrow involvement, in intensively treated patients with intermediate grade non-Hodgkin's lymphoma, is a risk factor for granulocytopenia and fever. NHL
62  1995 Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. CR, ESR, GHSG, HD, LDH
63  1989 Prognostic value of bone marrow biopsy in chronic lymphoid leukemia. A study of 98 initial bone marrow biopsies. MB